Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of Pittsburgh
National Cancer Institute (NCI)
Hoosier Cancer Research Network
Cancer Research UK
Wake Forest University Health Sciences
H. Lee Moffitt Cancer Center and Research Institute
Duke University
University of Maryland, Baltimore
Spectrum Pharmaceuticals, Inc
Stanford University
Amgen
M.D. Anderson Cancer Center
JS InnoPharm, LLC
Dartmouth-Hitchcock Medical Center
ProgenaBiome
NextPoint Therapeutics, Inc.